細胞分析市場：製品、プロセス、エンドユーザー別-2025-2030年の世界予測

細胞分析市場は、2023年に221億4,000万米ドルと評価され、2024年には242億5,000万米ドルに達すると予測され、CAGR 9.58%で成長し、2030年には420億3,000万米ドルに達すると予測されています。

細胞分析はライフサイエンスにおける重要なプロセスであり、研究、診断、治療開発の礎石として機能します。細胞の機能、特性、相互作用に関する洞察を得るために細胞を調べることが含まれます。細胞分析の必要性は、疾病の理解、薬剤の開発、個別化医療の進展への応用に由来します。その用途は創薬、がん研究、幹細胞研究など多岐にわたり、最終用途はヘルスケア機関、研究機関、バイオテクノロジー企業が中心です。市場成長の主な原動力は、ハイスループット・スクリーニングやシングル細胞分析技術などの技術的進歩、慢性疾患の有病率の上昇、細胞を用いた研究を支援する政府の取り組みなどです。自動化およびAI駆動の細胞分析機器の開発には機会が豊富にあり、効率性と精度の向上が約束されています。さらに、新規の再生医療や免疫療法研究における細胞分析の採用拡大により、大きな成長が見込まれます。しかし、先進的な細胞分析システムの高価格、サンプル調製の複雑さ、特定の細胞療法に関する倫理的懸念などの課題が、市場拡大の妨げになる可能性があります。また、これらの技術によって生成される膨大なデータ量に起因するデータ管理上の問題なども制約要因として挙げられます。これらの課題に対処するためには、コスト効率の高いソリューションの開発、プロセスの簡素化、データ解析能力の強化に重点を置いた技術革新が必要であろう。技術革新の最も有望な分野には、予測分析を改善するための機械学習アルゴリズムの統合や、ラボオンチップ・ソリューションを促進するための分析ツールの小型化が含まれます。これらのイノベーションは、様々な最終用途環境における拡張性とアクセシビリティを大幅に向上させることができます。市場はダイナミックで競争が激しく、企業は製品の差別化と付加価値サービスによって差別化を図る機会があります。競合情勢が進化し続ける中、分野横断的なアプローチを採用し、コラボレーションを促進することで先手を打つことが、市場情勢における成長を維持し、競争力を維持するために不可欠です。

市場力学：急速に進化する細胞分析市場の主要市場インサイトを公開

細胞分析市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患および感染症の罹患率の増加
  • 技術的に高度な製品と診断ラボのイントロダクション
  • ライフサイエンス分野への政府投資とバイオ医薬品・バイオテクノロジー産業の急速な拡大
• 市場抑制要因
  • 熟練した専門家の不足
• 市場機会
  • 研究開発および新製品開発のためのコラボレーション活動
  • 個別化医療における細胞分析の応用
• 市場の課題
  • 複雑で時間のかかる規制ガイドライン

ポーターの5つの力：細胞分析市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：細胞分析市場における外部からの影響の把握

外部マクロ環境要因は、細胞分析市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析細胞分析市場における競合情勢の把握

細胞分析市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス細胞分析市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞分析市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨細胞分析市場における成功への道筋を描く

細胞分析市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および感染症の発生率の増加
    • 技術的に高度な製品と診断ラボのイントロダクション
    • ライフサイエンス分野への政府投資とバイオ医薬品・バイオテクノロジー産業の急速な拡大
  • 抑制要因
    • 熟練した専門家の不足
  • 機会
    • 研究開発および新製品開発のためのコラボレーション活動
    • 個別化医療における細胞分析の応用
  • 課題
    • 複雑で時間のかかる規制ガイドライン
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 細胞分析市場：製品別

• 細胞カウンター
• 細胞マイクロアレイ
• フローサイトメトリー製品
• ハイコンテントスクリーニングシステム
• 顕微鏡
• QPCR製品
• 分光光度計

第7章 細胞分析市場：プロセス別

• 細胞カウントと品質管理
• 細胞識別
• 細胞相互作用
• 細胞増殖
• 細胞シグナル伝達経路またはシグナル伝達
• 細胞構造研究
• 細胞生存率
• 単一細胞解析
• ターゲットの特定と検証

第8章 細胞分析市場：エンドユーザー別

• 細胞培養コレクションリポジトリ
• 契約調査機関
• 病院および診断研究所
• 製薬・バイオテクノロジー企業
• 調査機関

第9章 南北アメリカの細胞分析市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の細胞分析市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの細胞分析市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• BioStatus Limited
• Carl Zeiss AG
• Cell Biolabs, Inc.
• Creative Bioarray
• Cytek Biosciences
• Danaher Corporation
• EVIDENT
• GE Healthcare
• Meiji Techno
• Merck KGaA
• Miltenyi Biotec B.V. & Co. KG
• Nanocellect Biomedical
• PerkinElmer Inc.
• Promega Corporation
• Sysmex America, Inc.
• Tecan Trading AG
• Thermo Fisher Scientific

LIST OF FIGURES

• FIGURE 1. CELL ANALYSIS MARKET RESEARCH PROCESS
• FIGURE 2. CELL ANALYSIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL ANALYSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELL ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELL ANALYSIS MARKET DYNAMICS
• TABLE 7. GLOBAL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL ANALYSIS MARKET SIZE, BY HIGH-CONTENT SCREENING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELL ANALYSIS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL ANALYSIS MARKET SIZE, BY QPCR PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELL ANALYSIS MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL COUNTING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL INTERACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL PROLIFERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL SIGNALING PATHWAY OR SIGNAL TRANSDUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL STRUCTURE STUDY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL VIABILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL ANALYSIS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CELL ANALYSIS MARKET SIZE, BY CELL CULTURE COLLECTION REPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CELL ANALYSIS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CELL ANALYSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 60. CHINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 63. INDIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. TAIWAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. TAIWAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 84. TAIWAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. THAILAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. THAILAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 87. THAILAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. VIETNAM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. VIETNAM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 90. VIETNAM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 93. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 95. DENMARK CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. DENMARK CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 97. DENMARK CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. EGYPT CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. EGYPT CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 100. EGYPT CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. FINLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. FINLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 103. FINLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. FRANCE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. FRANCE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 106. FRANCE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. GERMANY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. GERMANY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 109. GERMANY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. ISRAEL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. ISRAEL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 112. ISRAEL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. ITALY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. ITALY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 115. ITALY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 118. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. NIGERIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. NIGERIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 121. NIGERIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. NORWAY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. NORWAY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 124. NORWAY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. POLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. POLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 127. POLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. QATAR CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. QATAR CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 130. QATAR CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. RUSSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. RUSSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 133. RUSSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 136. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 139. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SPAIN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. SPAIN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 142. SPAIN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. SWEDEN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. SWEDEN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 145. SWEDEN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 148. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. TURKEY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. TURKEY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 151. TURKEY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 154. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
• TABLE 157. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 159. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

The Cell Analysis Market was valued at USD 22.14 billion in 2023, expected to reach USD 24.25 billion in 2024, and is projected to grow at a CAGR of 9.58%, to USD 42.03 billion by 2030.

Cell analysis is a critical process in life sciences, serving as a cornerstone in research, diagnostics, and therapeutic developments. It involves examining cells for insights into their functions, characteristics, and interactions. The necessity of cell analysis stems from its applications in understanding diseases, developing drugs, and advancing personalized medicine. Its applications are broad, including drug discovery, cancer research, and stem cell research, with end-use predominant in healthcare institutions, research organizations, and biotechnology firms. Market growth is primarily driven by technological advancements such as high-throughput screening and single-cell analysis technologies, rising prevalence of chronic disorders, and government initiatives supporting cell-based research. Opportunities abound in the development of automated and AI-driven cell analysis instruments, which promise increased efficiency and precision. Moreover, expanding adoption of cell analysis in novel regenerative medicine and immunotherapy research presents significant growth prospects. However, challenges such as high costs of advanced cell analysis systems, complexities in sample preparation, and ethical concerns regarding certain cell therapies may hinder market expansion. Limitations also include data management issues due to the vast amount of data generated by these technologies. To combat these challenges, emphasis on innovation could focus on developing cost-effective solutions, simplifying processes, and enhancing data analytics capabilities. The most promising areas for innovation include integrating machine learning algorithms to improve predictive analytics and the miniaturization of analysis tools to promote lab-on-a-chip solutions. These innovations can significantly enhance scalability and accessibility in various end-use environments. The market is dynamic and highly competitive, with opportunities for companies to differentiate themselves through product differentiation and value-added services. As the landscape continues to evolve, staying ahead by embracing cross-disciplinary approaches and fostering collaborations will be essential for sustaining growth and maintaining a competitive edge in the cell analysis market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Analysis Market

The Cell Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of chronic and infectious diseases
  • Introduction of technologically advanced products and diagnostic laboratories
  • Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
• Market Restraints
  • Limited availability of skilled professionals
• Market Opportunities
  • Collaboration activities for R&D and new product development
  • Applications of cell analysis in personalized medicine
• Market Challenges
  • Complex & time-consuming regulatory guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Cell Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Analysis Market

A detailed market share analysis in the Cell Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Analysis Market

A strategic analysis of the Cell Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Analysis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., BioStatus Limited, Carl Zeiss AG, Cell Biolabs, Inc., Creative Bioarray, Cytek Biosciences, Danaher Corporation, EVIDENT, GE Healthcare, Meiji Techno, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Nanocellect Biomedical, PerkinElmer Inc., Promega Corporation, Sysmex America, Inc., Tecan Trading AG, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Cell Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cell Counters, Cell Microarrays, Flow Cytometry Products, High-Content Screening Systems, Microscopes, QPCR Products, and Spectrophotometers.
• Based on Process, market is studied across Cell Counting & Quality Control, Cell Identification, Cell Interaction, Cell Proliferation, Cell Signaling Pathway or Signal Transduction, Cell Structure Study, Cell Viability, Single-Cell Analysis, and Target Identification & Validation.
• Based on End-User, market is studied across Cell Culture Collection Repositories, Contract Research Organizations, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of chronic and infectious diseases
    • 5.1.1.2. Introduction of technologically advanced products and diagnostic laboratories
    • 5.1.1.3. Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaboration activities for R&D and new product development
    • 5.1.3.2. Applications of cell analysis in personalized medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Complex & time-consuming regulatory guidelines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Analysis Market, by Product

• 6.1. Introduction
• 6.2. Cell Counters
• 6.3. Cell Microarrays
• 6.4. Flow Cytometry Products
• 6.5. High-Content Screening Systems
• 6.6. Microscopes
• 6.7. QPCR Products
• 6.8. Spectrophotometers

7. Cell Analysis Market, by Process

• 7.1. Introduction
• 7.2. Cell Counting & Quality Control
• 7.3. Cell Identification
• 7.4. Cell Interaction
• 7.5. Cell Proliferation
• 7.6. Cell Signaling Pathway or Signal Transduction
• 7.7. Cell Structure Study
• 7.8. Cell Viability
• 7.9. Single-Cell Analysis
• 7.10. Target Identification & Validation

8. Cell Analysis Market, by End-User

• 8.1. Introduction
• 8.2. Cell Culture Collection Repositories
• 8.3. Contract Research Organizations
• 8.4. Hospitals & Diagnostic Laboratories
• 8.5. Pharmaceutical & Biotechnology Companies
• 8.6. Research Institutes

9. Americas Cell Analysis Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cell Analysis Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cell Analysis Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies Inc.
• 2. Becton, Dickinson and Company
• 3. Bio-Rad Laboratories Inc.
• 4. BioStatus Limited
• 5. Carl Zeiss AG
• 6. Cell Biolabs, Inc.
• 7. Creative Bioarray
• 8. Cytek Biosciences
• 9. Danaher Corporation
• 10. EVIDENT
• 11. GE Healthcare
• 12. Meiji Techno
• 13. Merck KGaA
• 14. Miltenyi Biotec B.V. & Co. KG
• 15. Nanocellect Biomedical
• 16. PerkinElmer Inc.
• 17. Promega Corporation
• 18. Sysmex America, Inc.
• 19. Tecan Trading AG
• 20. Thermo Fisher Scientific